Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

European Commission awards orphan drug designation to SENS-401

Nov. 28, 2016

Sensorion reports results from phase I study of SENS-218 for inner ear lesions

Sep. 8, 2016

Auris Medical's phase III trial of Keylizen does not meet its two coprimary efficacy endpoints

Aug. 19, 2016

FDA's clinical hold on CGF-166 lifted

July 26, 2016

Auris Medical obtains fast track designation for Keyzilen

July 19, 2016

Strekin begins phase II study of STR-001

April 29, 2016

Boehringer Ingelheim and Kyoto University to investigate new drugs for sensorineural hearing loss

April 5, 2016

Otonomy launches Otiprio in U.S.

March 3, 2016

Oricula Therapeutics receives NIH grant to support development of ORC-13661

Feb. 4, 2016

3D-printed biomimetic tympanic membrane shows similar acoustic properties to human eardrum

Jan. 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...